Frequently Asked Questions

It depends on the peptide and how you obtain it. FDA-approved peptide drugs (like semaglutide and tirzepatide) are fully legal with a prescription. As of 2026, 14 peptides have been reclassified to Category 1, meaning licensed compounding pharmacies can legally prepare them with a physician prescription. Purchasing peptides labeled 'for research use only' from unregulated vendors is a legal gray area — these products are not approved for human use.

Category 1 means a compound can be used by licensed compounding pharmacies to prepare medications when prescribed by a physician. Category 2 means the compound is restricted and cannot be compounded. In February 2026, 14 peptides were moved from Category 2 back to Category 1, restoring legal compounding access.

The Pharmacy Compounding Advisory Committee (PCAC) is an FDA advisory body that evaluates whether specific compounds should be included on the 503A bulk drug substances list. Inclusion on this list provides the clearest legal pathway for compounding pharmacies to prepare these compounds. The PCAC is scheduled to review 7 peptides on July 23-24, 2026, with 5 more by February 2027.

A COA is a document from a laboratory that reports testing results for a specific batch of a product. For peptides, it typically includes HPLC purity analysis, mass spectrometry identity confirmation, and sometimes sterility testing. A legitimate COA from a third-party lab is the best way to verify that a peptide product contains what it claims at the advertised purity.

Look for clinics that require a physician consultation before prescribing, source from licensed compounding pharmacies, provide transparent pricing, and have verifiable physician credentials. Avoid any provider that sells peptides without a prescription or medical evaluation. Our clinic directory lists verified telehealth providers.

A compounding pharmacy prepares customized medications based on individual prescriptions — they mix, combine, or alter ingredients to create a formulation tailored to a patient's needs. A regular (retail) pharmacy dispenses commercially manufactured drugs. Compounding pharmacies operate under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act and are regulated by state boards of pharmacy.

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice. It has been studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects. It was reclassified to Category 1 in February 2026 and is scheduled for PCAC review on July 23, 2026.

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist. Tirzepatide (Mounjaro/Zepbound) is a dual GIP and GLP-1 receptor agonist. Both are FDA-approved for diabetes and weight management. Clinical trials suggest tirzepatide may produce greater weight loss, but both are effective. The choice depends on individual response, insurance coverage, and physician recommendation.

No. TruPeptide is an independent information platform. We do not sell, distribute, or facilitate the purchase of any peptides. We do not accept payment from vendors or clinics to influence our content or rankings. Our revenue model is based on subscriptions, data licensing, and clearly-labeled sponsored educational content — never product sales or affiliate commissions.

Trust scores are calculated from a weighted combination of COA verification data (purity, testing frequency, lab independence), community reviews, operational transparency, and complaint resolution. No vendor or clinic can pay to influence their score. The methodology is transparent and every score is auditable. Trust scoring is currently in development.

No. All content on TruPeptide is for educational and informational purposes only. We do not provide medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before starting any peptide therapy. Our compound profiles present published research and regulatory information — they do not constitute endorsements of any compound for any condition.